Company / Depreciation & Amortization
BioAtla, Inc. Depreciation & Amortization History
FY2021-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$1.2M
FY2022
5-year range
$1.2M / $1.3M
FY2021-FY2022
Trend
-9.8%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$1M in FY2022.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, depreciation & amortization decreased 9.8% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.29 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $1.2M | -9.8% |
| FY2021 | $1.3M | - |
As of FY2022 · SEC Form 10-K · Last checked Jun 21, 2026